MYOS RENS Technology Inc. Announces Positive Top-Line Results from a Randomized, Double-Blind, Placebo-Controlled Study by Kansas State University
January 15, 2019 at 05:30 pm IST
Share
MYOS RENS Technology Inc. announced positive top-line results from a randomized, double-blind, placebo-controlled study by Kansas State University evaluating the impact of Fortetropin on attenuating muscle atrophy following a common surgical procedure known as tibial-plateau leveling osteotomy ("TPLO") in 100 dogs. In the weeks that follow TPLO surgery, immobilization of the dog's limb is required and the operated limb frequently shows significant muscle loss due to muscle disuse atrophy. Key findings of the study were: Fortetropin prevented the loss of muscle mass in these dogs as measured by the thigh circumference in their affected and unaffected limbs. Fortetropin-supplemented dogs had a more significant improvement in percentage of weight supported by the affected limb as determined by force plate stance analysis (more rapid return to normal stance force distribution) than the placebo group. Fortetropin prevented a rise in serum myostatin levels. Myostatin is a protein that prevents muscle growth.
MedAvail Holdings, Inc. is a pharmacy technology and services company. The Company is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. It operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.